Pelthos Therapeutics Inc. - PTHS
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 17, 2026 | SCHEDULE 13G/A | Ikarian Capital, LLC | 8.4% | 255,758 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Neil Shahrestani | 8.4% | 255,758 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | 3i, LP | 9.9% | 318,886 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | 3i Management LLC | 9.9% | 318,886 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Maier Joshua Tarlow | 9.9% | 318,886 | View |
| Nov 14, 2025 | SCHEDULE 13G | Murchinson Ltd. | 9.1% | 280,000 | View |
| Nov 14, 2025 | SCHEDULE 13G | Marc Bistricer | 9.1% | 280,000 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Ikarian Capital, LLC | 6.1% | 186,408 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Neil Shahrestani | 6.1% | 186,408 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.